SLC25A32
Basic information
Region (hg38): 8:103398635-103415189
Links
Phenotypes
GenCC
Source:
- exercise intolerance, riboflavin-responsive (Limited), mode of inheritance: Unknown
- exercise intolerance, riboflavin-responsive (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Exercise intolerance, riboflavin-responsive | AR | Biochemical | The condition involves recurrent exercise intolerance, and medical management (with oral riboflavin) has been described as being efficacious related to both biochemical and clinical parameters | Biochemical; Musculoskeletal | 26933868 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SLC25A32 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 24 | 28 | ||||
missense | 59 | 64 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 3 | |||||
splice region | 2 | 7 | 1 | 10 | ||
non coding | 27 | 27 | 54 | |||
Total | 0 | 0 | 72 | 55 | 29 |
Variants in SLC25A32
This is a list of pathogenic ClinVar variants found in the SLC25A32 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-103400160-C-A | Benign (Jul 31, 2018) | |||
8-103400246-CA-C | Benign (Jul 15, 2018) | |||
8-103400289-A-T | Benign (Jul 31, 2018) | |||
8-103400407-G-A | SLC25A32-related disorder | Likely benign (Jan 28, 2021) | ||
8-103400426-T-C | Likely benign (Jan 04, 2024) | |||
8-103400432-G-A | Likely benign (Mar 08, 2022) | |||
8-103400445-T-C | Uncertain significance (Jan 24, 2023) | |||
8-103400447-T-C | Likely benign (Jan 13, 2024) | |||
8-103400457-T-G | Uncertain significance (Nov 15, 2023) | |||
8-103400460-T-C | Exercise intolerance, riboflavin-responsive • SLC25A32-related disorder | Benign/Likely benign (Jan 29, 2024) | ||
8-103400498-A-C | not specified | Uncertain significance (Jun 12, 2023) | ||
8-103400500-T-A | not specified | Uncertain significance (Aug 21, 2022) | ||
8-103400500-T-C | not specified | Uncertain significance (Dec 21, 2023) | ||
8-103400528-TCCA-T | Uncertain significance (Jun 22, 2022) | |||
8-103400533-C-T | SLC25A32-related disorder | Benign (Jan 21, 2024) | ||
8-103400536-C-T | Uncertain significance (Mar 06, 2023) | |||
8-103400537-G-A | SLC25A32-related disorder | Uncertain significance (Aug 28, 2023) | ||
8-103400552-G-C | Uncertain significance (Nov 20, 2022) | |||
8-103400556-G-GA | Benign (Aug 10, 2021) | |||
8-103400602-C-T | Benign (Jul 31, 2018) | |||
8-103400707-C-T | Benign (Jul 31, 2018) | |||
8-103401273-C-T | Benign (Sep 15, 2019) | |||
8-103401307-T-TC | Benign (Aug 14, 2018) | |||
8-103401496-G-T | Benign/Likely benign (Jan 22, 2024) | |||
8-103401500-T-C | Likely benign (Feb 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SLC25A32 | protein_coding | protein_coding | ENST00000297578 | 7 | 16555 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
6.76e-9 | 0.260 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.369 | 165 | 179 | 0.922 | 0.00000908 | 2002 |
Missense in Polyphen | 60 | 81.807 | 0.73343 | 915 | ||
Synonymous | -1.31 | 85 | 71.0 | 1.20 | 0.00000366 | 626 |
Loss of Function | 0.589 | 14 | 16.6 | 0.844 | 7.83e-7 | 215 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000393 | 0.000391 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000930 | 0.0000924 |
European (Non-Finnish) | 0.000161 | 0.000158 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000304 | 0.000294 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Transports folate across the inner membranes of mitochondria.;
- Pathway
- miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Metabolism;Metabolism of folate and pterines;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- loftool
- 0.518
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.01
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.335
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Slc25a32
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); craniofacial phenotype;
Gene ontology
- Biological process
- glycine metabolic process;folic acid transport;FAD transmembrane transport;folic acid metabolic process;folate import into mitochondrion
- Cellular component
- mitochondrion;mitochondrial inner membrane;integral component of membrane
- Molecular function
- folic acid transmembrane transporter activity;FAD transmembrane transporter activity